Artificial intelligence in melanoma diagnosis: ethical considerations and clinical implementation

Area of Science:

• Dermatology
• Medical Artificial Intelligence
• Oncology

Background:

• Artificial intelligence (AI) is increasingly explored for medical applications.
• Early cancer detection, especially melanoma, is crucial for patient outcomes.
• Existing AI systems show potential but face implementation hurdles.

Purpose of the Study:

• To evaluate the potential of AI in dermatology for melanoma diagnosis.
• To identify current advancements and challenges in AI-driven dermatological diagnostics.
• To discuss the implications of AI in clinical practice and patient care.

Main Methods:

• Review of current AI-based systems (e.g., DermaSensor, Nevisense) and open-source models (e.g., All Data Are Ext).
• Analysis of reported sensitivity and promise of these AI models.
• Identification of ethical, practical, and privacy concerns associated with AI in dermatology.

Main Results:

• AI systems demonstrate high sensitivity in melanoma diagnosis.
• Specific AI tools like DermaSensor, Nevisense, and ADAE show significant promise.
• Ethical, practical, and privacy concerns are significant barriers to AI adoption.

Conclusions:

• AI holds significant potential for improving early melanoma detection.
• Addressing patient data privacy, transparency, and clinical discrepancies is essential.
• Further research, regulatory frameworks, and open dialogue are needed to integrate AI responsibly in dermatology.